A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) — Stella
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(13 sites)
United States
Memorial Sloan Kettering Cancer Center, New York, New York
Australia
Gold Coast Hospital and Health Service, Southport, Queensland
South Korea
Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do
Seoul National University Hospital, Seoul
Severance Hospital; Division of Hematology, Seoul
Samsung Medical Center, Seoul
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul
Ulsan University Hospital, Ulsan
United Kingdom
Aberdeen Royal Infirmary, Aberdeen, Aberdeenshire
Royal Cornwall Hospital National Health Service (NHS) Foundation Trust, Truro, Cornwall
University Hospitals Plymouth National Health Service (NHS) Foundation Trust - Hematology, Plymouth, Devon
Norfolk and Norwich University Hospital National Health Service (NHS) Foundation Trust, Norwich, Norfolk